Lexaria Bioscience Corp (LEXX) — Capital Reinvestment Ratio

Latest as of November 2013: 0.37x

Lexaria Bioscience Corp (LEXX) has a Capital Reinvestment Ratio of 0.37x as of November 2013, meaning it reinvests 0% of its operating cash flow ($74.27K) in capital expenditures ($27.23K). Check Lexaria Bioscience Corp tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.37x
Capex / Operating Cash Flow

Operating Cash Flow

$74.27K
USD

Capital Expenditures

$27.23K
USD

Data as of

Nov 2013
Most recent filing

Lexaria Bioscience Corp Capital Reinvestment Ratio (2007–2014)

This chart tracks Lexaria Bioscience Corp's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see Lexaria Bioscience Corp cash conversion from operations.

Annual Capital Reinvestment Ratio for Lexaria Bioscience Corp (2007–2014)

Year-by-year Capital Reinvestment Ratio for Lexaria Bioscience Corp from 2007 to 2014. See free cash flow generation of Lexaria Bioscience Corp to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2014 0.29x $321.00K $91.61K ▲ +0.0%
2013 0.29x $321.00K $91.61K ▲ +0.0%
2012 0.29x $321.00K $91.61K ▼ -85.8%
2011 2.02x $135.94K $274.13K ▼ -77.9%
2010 9.13x $109.84K $1.00 Million ▼ -54.5%
2007 20.06x $29.04K $582.43K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow